ny People Have Been Vaccinated in the US?: Synthesizes and displays data originating at the Centers for Disease Control and Prevention [CDC] accounting for distribution and administration of doses of all three authorized vaccines (those made by Pfizer-BioNTech, Moderna, and Johnson & Johnson). The presentation is made and updated (11/01/21) by USA Today.
Understanding and Communicating about COVID-19 Vaccine Efficacy, Effectiveness, and Equity: Summarizes social, behavioral, and decision science research relevant to communicating how well COVID-19 vaccines work, and how equitably they are being distributed. It offers practical strategies for both the process and the content of such communication, recognizing that people respond to both how they learn about something and what they learn about it. This rapid expert consultation was produced through the Societal Experts Action Network [SEAN] of the National Academies of Sciences, Engineering, and Medicine in affiliation with U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response.
New Tool Tracks Vaccination and Vaccine Hesitancy Rates Across Geographies, Population Groups: Uses data from the U.S. Census Bureau’s Household Pulse Survey, which has recently added a new series of questions about COVID-19 vaccinations and attitudes toward them. This new Census Bureau data visualization tool aims to provide insights into the public’s feelings about COVID-19 vaccines in near real time. The interactive visualization allows data users to explore national and state vaccination rates; percentage of people by state hesitant to get a COVID-19 vaccine; most common reasons cited for hesitancy to get a vaccine; vaccination rates by population subgroups; and vaccine hesitancy rates by population subgroups. The data visualization tools will enable analysis of how vaccination and vaccine hesitance rates might vary over time.
Public Health Messaging Vital for COVID-19 Vaccine Uptake: Leaders Partnering on Communications: Reports recent findings from large-scale surveys detailing attitudes toward receiving or deferring acceptance of COVID-19 vaccination among various dimensions of the American public. Public health messengers are working with great urgency to persuade Americans to get immunized. A December survey from Kaiser Family Foundation found 71% of adults would get a COVID-19 vaccine that was determined safe by scientists and available for free; but more than a quarter were still hesitant.
Coronavirus (COVID-19) Update (5/10/21): FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic: Announces the U.S. Food and Drug Administration [FDA]’s expansion of emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to include adolescents 12 through 15 years of age. Acting FDA Commissioner Janet Woodcock MD explained, “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.”
Fact Sheet for Recipients and Caregivers: Emergency Use Authorization (EUA) of the Pfizer-Biotech COVID-19 Vaccine To Prevent Coronavirus Disease 2019 (COVID-19) in Individuals 12 Years Of Age and Older: Provides information from the U.S. Food and Drug Administration [FDA] to help parents, caregivers, and recipients to understand the risks and benefits of the Pfizer-BioNTech COVID-19 Vaccine. As of May 10, 2021 children and adolescents as young as age 12 may receive that vaccine to help control the current pandemic.
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization (EUA) of the Pfizer-Biotech COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19): Updates instructions of the U.S. Food and Drug Administration [FDA] for COVID-19 Vaccinatio